Group structure
11 companies in 5 countries
Loading your pageโฆ
Loading your pageโฆ
11 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 112
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Abirateron MSN 250 mg filmom obloลพene tableteFilmom obloลพena tableta | Abiraterone | Croatia | Authorised | 2024 |
| Abirateron MSN 500 mg filmom obloลพene tableteFilmom obloลพena tableta | Abiraterone | Croatia | Marketed | 2024 |
| AZACITIDINE FOR INJECTION100 mg / vial ยท Powder For Suspension | Azacitidine | Canada | Authorised | |
| Bosutinib MSN 100 mg filmom obloลพene tableteFilmom obloลพena tableta | Bosutinib | Croatia | Not marketed | 2025 |
| Bosutinib MSN 400 mg filmom obloลพene tableteFilmom obloลพena tableta | Bosutinib | Croatia | Not marketed | 2025 |
| Bosutinib MSN 500 mg filmom obloลพene tableteFilmom obloลพena tableta | Bosutinib | Croatia | Not marketed | 2025 |
| BRIVARACETAM10mg/ml ยท Solution | Brivaracetam | United States | Marketed | 2026 |
| Clizay 100 mg filmom obloลพene tableteFilmom obloลพena tableta | Brivaracetam | Croatia | Not marketed | 2026 |
| Clizay 25 mg filmom obloลพene tableteFilmom obloลพena tableta | Brivaracetam | Croatia | Not marketed | 2026 |
| Clizay 50 mg filmom obloลพene tableteFilmom obloลพena tableta | Brivaracetam | Croatia | Not marketed | 2026 |
| DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE10mg; 5mg base ยท Tablet | Dapagliflozin, Saxagliptin | United States | Marketed | 2026 |
| Daplemsen 10 mg filmom obloลพene tableteFilmom obloลพena tableta | Dapagliflozin | Croatia | Not marketed | 2026 |
| Daplemsen 5 mg filmom obloลพene tableteFilmom obloลพena tableta | Dapagliflozin | Croatia | Not marketed | 2026 |
| DEXRAZOXANE HYDROCHLORIDE250mg base/vial | 500mg base/vial ยท Injectable | Dexrazoxane | United States | Marketed | 2004 |
| Dimetilfumarat MSN 120 mg tvrde ลพeluฤanootporne kapsuleลฝeluฤanootporna kapsula, tvrda | Dimethyl | Croatia | Marketed | 2024 |
| Dimetilfumarat MSN 240 mg tvrde ลพeluฤanootporne kapsuleลฝeluฤanootporna kapsula, tvrda | Dimethyl | Croatia | Marketed | 2024 |
| Eltrombopag MSN 25 mg filmom obloลพene tableteFilmom obloลพena tableta | Eltrombopag | Croatia | Not marketed | 2025 |
| Eltrombopag MSN 50 mg filmom obloลพene tableteFilmom obloลพena tableta | Eltrombopag | Croatia | Not marketed | 2025 |
| Eltrombopag MSN 75 mg filmom obloลพene tableteFilmom obloลพena tableta | Eltrombopag | Croatia | Not marketed | 2025 |
| Eplerenon MSN 25 mg filmom obloลพene tableteFilmom obloลพena tableta | Eplerenone | Croatia | Marketed | 2026 |
| Eplerenon MSN 50 mg filmom obloลพene tableteFilmom obloลพena tableta | Eplerenone | Croatia | Marketed | 2026 |
| IRBESARTAN150mg | 300mg | 75mg ยท Tablet | Irbesartan | United States | Marketed | 2012 |
| Isovurex 10 mg tableteTableta | Ezetimibe | Croatia | Authorised | 2024 |
| IVABRADINE HYDROCHLORIDE5mg base | 7.5mg base ยท Tablet | Ivabradine | United States | Marketed | 2021 |
| Jesoxade 10 mg filmom obloลพene tableteFilmom obloลพena tableta | Macitentan | Croatia | Marketed | 2026 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Croatia | 56 | 56 | 0 | CompaniesAll medicines |
| Saudi Arabia | 29 | 29 | 0 | CompaniesAll medicines |
| United States | 26 | 13 | 13 | CompaniesAll medicines |
| Canada | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Serbia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 published list; https://assets.publishing.service.gov.uk/media/6ac65fc6f1ba855cc196a8ba/New_Manufacturing_and_Wholesale_Dealer_Licences_-_October_2026.csv; acquired 2026-10-14T16:17:18.644817+00:00; CSV-to-licence-event projections are adaptations under OGL v3.0.
Licence: Open Government Licence v3.0; Crown copyright MHRA published licence history
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.